Time for Cooperation in Health Economics among the Modelling Community
@article{Arnold2012TimeFC, title={Time for Cooperation in Health Economics among the Modelling Community}, author={R. Arnold and S. Ekins}, journal={PharmacoEconomics}, year={2012}, volume={28}, pages={609-613} }
1 Master of Public Health Program, Mount Sinai School of Medicine, Department of Preventive Medicine, New York, New York, USA 2 Arnold Consultancy and Technology LLC, New York, New York, USA 3 Arnold and Marie Schwartz College of Pharmacy, Brooklyn, New York, USA 4 Collaborations in Chemistry, Jenkintown, Pennsylvania, USA 5 Collaborative Drug Discovery, Burlingame, California, USA 6 Department of Pharmaceutical Sciences, University of Maryland, Baltimore, Maryland, USA 7 Department of… CONTINUE READING
Figures and Topics from this paper
Figures
18 Citations
Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling
- Medicine
- PharmacoEconomics
- 2017
- 3
- PDF
The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood
- Computer Science, Medicine
- PharmacoEconomics
- 2019
- 6
- PDF
To model or not to model: lessons from two vaccinations
- Medicine
- The European Journal of Health Economics
- 2011
- 1
- PDF
Can You Repeat That? Exploring the Definition of a Successful Model Replication in Health Economics
- Computer Science, Medicine
- PharmacoEconomics
- 2019
- 2
DISEASE PREVALANCE , PHARMACOECONOMIC STUDY AND PRESCRIPTION PATTERN STUDY IN PEDIATRIC PATIENTS
- 2017
Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
- Medicine
- Clinical and Molecular Allergy
- 2017
- 5
References
SHOWING 1-10 OF 44 REFERENCES
Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.
- Computer Science, Medicine
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
- 2003
- 1,058
- PDF
How Can Cost-Effectiveness Information Help Control Unsustainable Growth in U.S. Health Care Spending?
- Medicine
- Annals of Internal Medicine
- 2009
- 4
The pharmaco-economics of peri-operative beta-blocker and statin therapy in South Africa.
- Medicine
- South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
- 2006
- 14
To model or not to model: lessons from two vaccinations
- Medicine
- The European Journal of Health Economics
- 2011
- 1
- PDF
Cost-effectiveness analysis: should it be required for drug registration and beyond?
- Medicine
- Drug discovery today
- 2007
- 7